Stéphane Bancel
French businessman (born 1972)
From Wikipedia, the free encyclopedia
Stéphane Bancel (born 1972)[1] is a French billionaire businessman. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux. Bancel is a partner at Flagship Pioneering, and has been on the boards of Indigo Agriculture, Boston's Museum of Science, and Qiagen. As of May 2023, his net worth was estimated at US$4.1 billion, owning about 8% of Moderna.[2]
University of Minnesota (MS)
Harvard University (MBA)
Stéphane Bancel | |
|---|---|
Stéphane Bancel | |
| Born | 1972 (age 53–54) Marseille, France |
| Education | CentraleSupélec (BS) University of Minnesota (MS) Harvard University (MBA) |
| Spouse | Brenda Bancel |
| Children | 2 |
Early life
Bancel was born in Marseille, France. His father and mother were an engineer and doctor, respectively. They divorced when he was eight.[3] He enjoyed computers, math, and science during his childhood.[4]
Bancel studied engineering at CentraleSupélec (former École Centrale Paris) and biological engineering at the University of Minnesota, earning master's degrees at both institutions.[5] He went on to earn an MBA from Harvard Business School.[6]
Career
Bancel was a sales director at Eli Lilly and Company, eventually becoming head of operations for Belgium.[6] In 2007, he became CEO of French diagnostics company BioMérieux, and was credited with improving the company's margins.[6]
In 2011, Bancel joined Moderna as the CEO. Stat reported that Bancel led a highly secretive culture with little outside review of its science or research.[6]
